Enoxaparin for thromboprophylaxis in overweight and obese patients: a prescribing audit at a tertiary hospital
Open Access
- 11 August 2019
- journal article
- research article
- Published by Wiley in Journal of Pharmacy Practice and Research
- Vol. 49 (4), 376-379
- https://doi.org/10.1002/jppr.1524
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Once versus twice daily injection of enoxaparin for thromboprophylaxis in bariatric surgery: effects on antifactor Xa activity and procoagulant microparticles. A randomized controlled studySurgery for Obesity and Related Diseases, 2015
- Adjusted-Dose Enoxaparin for VTE Prevention in the Morbidly ObeseJournal of Pharmacy Technology, 2015
- Enoxaparin Dosing After Cesarean Delivery in Morbidly Obese WomenObstetrics & Gynecology, 2015
- Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatientsThrombosis and Haemostasis, 2014
- Prospective comparison of three enoxaparin dosing regimens to achieve target anti‐factor Xa levels in hospitalized, medically ill patients with extreme obesityAmerican Journal of Hematology, 2012
- Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patientsThrombosis Research, 2010
- Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgerySurgical Endoscopy, 2008
- Anti-Xa Levels in Bariatric Surgery Patients Receiving Prophylactic EnoxaparinObesity Surgery, 2007
- A Comparison of Two Different Prophylactic Dose Regimens of Low Molecular Weight Heparin in Bariatric SurgeryObesity Surgery, 2002